racial disparities: american patients with aml
Published 3 years ago • 71 plays • Length 3:00Download video MP4
Download video MP3
Similar videos
-
2:41
addressing differences in how black patients with myeloma may present compared to other ethnicities
-
2:39
racial and ethnic disparities in aml: outcomes for hispanic patients
-
3:42
addressing racial disparities in the treatment of multiple myeloma in america
-
1:00
racial differences in treatment and survival among older patients with multiple myeloma
-
3:25
socioeconomic and racial disparities in myeloma trial recruitment
-
4:09
the racial disparities between treatment availability for patients with cll
-
0:48
b-cell receptor signaling proteins as biomarkers of progression in cll
-
4:05
apollo: ato-atra versus standard atra chemotherapy for patients with newly diagnosed high-risk apl
-
9:57
quadruplet therapies for treating mm: the current evidence and the findings of a phase ii trial
-
1:59
phase i study of pevonedistat, azacitidine, and venetoclax in patients with r/r aml
-
1:12
cpx-351 with venetoclax in r/r aml: results of a phase ib study
-
1:55
diagnosing and treating aml: the role of mutational profiling
-
2:09
heart transplantation in attr amyloidosis
-
0:42
haploidentical transplant in argentina
-
0:44
predictors of poor response to azacitidine, venetoclax, and magrolimab in tp53-mutated aml
-
4:22
the role of mrd in aml
-
1:15
the diagnosis and management of mds/mpn with neutrophilia (atypical cml)
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
3:08
hypomethylating agents in aml
-
0:38
optimal time for allo-hsct in aml
-
0:55
the role of rna modifications in mds and aml